SCHLAP1 expression is revealed as a predictor for PCa aggressiveness, with highly significant hazard ratios for predicting biochemical recurrence, clinical progression, and PCa-specific mortality in a large cohort of localized PCa ( n = 235, median follow-up 8.1 years).
1
—
—